1. Home
  2. MRSN vs NTZ Comparison

MRSN vs NTZ Comparison

Compare MRSN & NTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • NTZ
  • Stock Information
  • Founded
  • MRSN 2001
  • NTZ 1959
  • Country
  • MRSN United States
  • NTZ Italy
  • Employees
  • MRSN N/A
  • NTZ N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • NTZ Home Furnishings
  • Sector
  • MRSN Health Care
  • NTZ Consumer Discretionary
  • Exchange
  • MRSN Nasdaq
  • NTZ Nasdaq
  • Market Cap
  • MRSN 40.7M
  • NTZ 39.0M
  • IPO Year
  • MRSN 2017
  • NTZ 1993
  • Fundamental
  • Price
  • MRSN $0.36
  • NTZ $3.51
  • Analyst Decision
  • MRSN Strong Buy
  • NTZ
  • Analyst Count
  • MRSN 5
  • NTZ 0
  • Target Price
  • MRSN $5.75
  • NTZ N/A
  • AVG Volume (30 Days)
  • MRSN 2.3M
  • NTZ 4.0K
  • Earning Date
  • MRSN 08-12-2025
  • NTZ 06-27-2025
  • Dividend Yield
  • MRSN N/A
  • NTZ N/A
  • EPS Growth
  • MRSN N/A
  • NTZ N/A
  • EPS
  • MRSN N/A
  • NTZ N/A
  • Revenue
  • MRSN $34,006,000.00
  • NTZ $330,051,765.00
  • Revenue This Year
  • MRSN N/A
  • NTZ N/A
  • Revenue Next Year
  • MRSN $1.30
  • NTZ N/A
  • P/E Ratio
  • MRSN N/A
  • NTZ N/A
  • Revenue Growth
  • MRSN N/A
  • NTZ N/A
  • 52 Week Low
  • MRSN $0.26
  • NTZ $3.07
  • 52 Week High
  • MRSN $2.83
  • NTZ $6.27
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 46.82
  • NTZ 38.10
  • Support Level
  • MRSN $0.35
  • NTZ $3.51
  • Resistance Level
  • MRSN $0.39
  • NTZ $4.40
  • Average True Range (ATR)
  • MRSN 0.03
  • NTZ 0.08
  • MACD
  • MRSN -0.00
  • NTZ -0.06
  • Stochastic Oscillator
  • MRSN 12.30
  • NTZ 0.00

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About NTZ Natuzzi S.p.A.

Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.

Share on Social Networks: